Susan Fox, PhD, ChB, MB BCh

Translational studies of new treatments for movement disorders, including phase II and phase IIII clinical studies.
Neuropharmacology. 2018 Jun 01;:
Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM
Parkinsonism Relat Disord. 2018 May 05;:
Li MH, Mestre TA, Fox SH, Taati B
Curr Opin Neurol. 2018 May 08;:
Kulisevsky J, Oliveira L, Fox SH
Front Aging Neurosci. 2018;10:120
Martinez M, Multani N, Anor CJ, Misquitta K, Tang-Wai DF, Keren R, Fox S, Lang AE, Marras C, Tartaglia MC
Mov Disord. 2018 Mar 23;:
Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C, Movement Disorder Society Evidence-Based Medicine Committee
Can J Neurol Sci. 2018 Jan;45(1):23-29
Bruno V, Freitas ME, Mancini D, Lui JP, Miyasaki J, Fox SH
Neuropharmacology. 2017 Nov 29;:
Johnston TH, Versi E, Howson PA, Ravenscroft P, Fox SH, Hill MP, Reidenberg BE, Corey R, Brotchie JM
Mov Disord. 2017 Nov 13;:
Wagle Shukla A, Fox S
Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3377-3380
Li MH, Mestre TA, Fox SH, Taati B

Pages